Agenus Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AGEN Nasdaq 2836 www.agenusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agenus Inc.

Align Technology's Q1 Earnings on Deck: Here's What to Expect - Apr 21st, 2026 9:31 am
Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026 - Apr 21st, 2026 8:00 am
Viking Therapeutics Gears Up for Q1 Earnings: Here's What to Expect - Apr 21st, 2026 6:35 am
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs - Apr 21st, 2026 6:00 am
Is Agenus (AGEN) Outperforming Other Medical Stocks This Year? - Apr 20th, 2026 7:40 am
Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings - Apr 20th, 2026 6:35 am
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal Cancer - Apr 17th, 2026 2:43 pm
Will Declining Premiums & Higher MCR Weigh on MOH Q1 Earnings? - Apr 17th, 2026 11:40 am
Will Robust Cardiovascular Performance Fuel BSX's Q1 Earnings? - Apr 17th, 2026 11:34 am
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi - Apr 16th, 2026 7:40 am
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results? - Apr 16th, 2026 7:18 am
Here's How Quest Diagnostics Is Placed Ahead of Q1 Earnings - Apr 15th, 2026 7:19 am
Will Robust Medical Business Performance Fuel ABT's Q1 Earnings? - Apr 15th, 2026 6:47 am
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study - Apr 14th, 2026 10:14 am
Agenus (AGEN) is a Great Momentum Stock: Should You Buy? - Apr 14th, 2026 10:00 am
Can Agenus (AGEN) Run Higher on Rising Earnings Estimates? - Apr 3rd, 2026 10:20 am
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy - Apr 3rd, 2026 10:00 am
Has Agenus (AGEN) Outpaced Other Medical Stocks This Year? - Apr 3rd, 2026 7:40 am
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026 - Apr 3rd, 2026 5:30 am
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer - Apr 1st, 2026 5:30 am